Cargando…
Loss of the xeroderma pigmentosum group B protein binding site impairs p210 BCR/ABL1 leukemogenic activity
Previous studies have demonstrated that p210 BCR/ABL1 interacts directly with the xeroderma pigmentosum group B (XPB) protein, and that XPB is phosphorylated on tyrosine in cells that express p210 BCR/ABL1. In the current study, we have constructed a p210 BCR/ABL1 mutant that can no longer bind to X...
Autores principales: | Pannucci, N L, Li, D, Sahay, S, Thomas, E K, Chen, R, Tala, I, Hu, T, Ciccarelli, B T, Megjugorac, N J, Adams III, H C, Rodriguez, P L, Fitzpatrick, E R, Lagunoff, D, Williams, D A, Whitehead, I P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3763389/ https://www.ncbi.nlm.nih.gov/pubmed/23955590 http://dx.doi.org/10.1038/bcj.2013.36 |
Ejemplares similares
-
Contributions of the RhoGEF activity of p210 BCR/ABL to disease progression
por: Tala, Ilona, et al.
Publicado: (2012) -
Xeroderma pigmentosum
por: Lehmann, Alan R, et al.
Publicado: (2011) -
Xeroderma Pigmentosum
por: Srivastava, Gautam, et al.
Publicado: (2021) -
Camouflage in xeroderma pigmentosum
por: Krishnaswamy, Gayathri, et al.
Publicado: (2016) -
Xeroderma pigmentosum et Dermoscopie
por: Inani, Kawtar, et al.
Publicado: (2013)